Salesforce's Anthropic Bet Likely Worth 'Tens of Billions' — And Benioff Plans to Cash In

Salesforce CEO Marc Benioff said the company may sell its Anthropic stake—acquired for hundreds of millions and potentially now worth tens of billions—to repay debt issued for its record $25 billion accelerated share repurchase. The buyback immediately retired roughly 103 million shares, while Anthropic-related investment gains added $2.6 billion to Salesforce's latest quarterly profit. A sale could convert volatile non-cash gains into debt reduction, but timing is uncertain because Anthropic remains private and Salesforce expects to spend about $300 million on its AI tokens this year.

Analysis

The investable issue is not the mark itself but whether CRM can convert a Level 3 asset into unrestricted cash without a valuation discount, transfer restrictions, or adverse tax leakage. A full debt-funded buyback unwind through asset monetization would improve net-interest expense and protect the EPS accretion already embedded in consensus; at a 4-5% all-in borrowing cost, each $10B of debt retired is worth roughly $400-500M of annual pretax earnings. Until transaction terms are disclosed, the market should not capitalize the stated paper value at par.

Near term, this raises the quality-of-earnings discount rather than removes it: investors will separate recurring subscription growth and operating margin from investment marks, particularly if strategic-gain volatility has become material to reported EPS. Over the next 1-3 months, a disclosed secondary sale, tender, or debt-repayment commitment would be a positive catalyst because it converts an opaque gain into lower leverage. Conversely, no monetization pathway by the next earnings call leaves CRM exposed to a reversal in private-market marks and renewed scrutiny of core growth.

The less obvious strategic risk is bargaining power. CRM is both economically exposed to and operationally dependent on a model supplier; reducing ownership does not reduce token-cost exposure. If AI coding consumption scales faster than monetizable AI-agent revenue, gross-margin pressure could emerge even as the equity stake is monetized. The contrarian view is that deleveraging may be neutral-to-negative for the multiple if investors interpret it as management monetizing a peak private valuation rather than demonstrating durable software cash-flow acceleration.

Key Decisions for Investors

• Maintain a neutral-to-underweight CRM stance into the next earnings release; do not underwrite strategic-investment gains in recurring EPS. Reassess long exposure only if management quantifies cash proceeds, tax/lockup terms, debt retired, and a path for AI revenue to exceed incremental inference expense.
• For a 1-3 month event trade, buy CRM only after a binding secondary-sale or debt-tender announcement, preferably against a short IGV hedge to isolate the balance-sheet catalyst. Target a 5-8% relative rerating; exit if proceeds are materially below carrying value or are not earmarked for debt reduction.
• If CRM rallies on an unpriced monetization claim before transaction details, consider a tactical short CRM versus long IGV for 4-8 weeks. Thesis is falsified by disclosed realizable proceeds sufficient to retire a substantial portion of acquisition/share-repurchase debt and reaffirmed core subscription-growth guidance.
• Set an earnings watch item for AI-related gross-margin commentary, annualized token spend, and the split between operating earnings and strategic-investment income. A widening consumption-versus-monetization gap is the key 6-18 month downside catalyst even if the stake is sold.